Brief: Immunome Announces Data Demonstrating Covid-19 Antibody Cocktail Potently Clears Omicron Ba.1 Variant In Hamster Model And Retains Activity Against Ba.2 Subvariant
19/05/2022 15:37
Immunome Inc IMNM.O :
* IMMUNOME ANNOUNCES DATA DEMONSTRATING COVID-19 ANTIBODY
COCKTAIL
POTENTLY CLEARS OMICRON BA.1 VARIANT IN HAMSTER MODEL AND
RETAINS ACTIVITY AGAINST BA.2 SUBVARIANT
* IMMUNOME INC - DATA SHOW THAT COMBINATION OF TWO
ANTIBODIES IN
IMMUNOME'S COCKTAIL SUCCESSFULLY NEUTRALIZED OMICRON VARIANT IN
VIVO IN HAMSTERS
* IMMUNOME INC - IMM20253 ANTIBODY ALSO RETAINED ACTIVITY
AGAINST
BA.2 SUBVARIANT IN PSEUDOVIRUS TESTING IN VITRO, WITH ADDITIONAL
TESTING UNDERWAY
Source text for Eikon: ID:nBw8sMGdJa
Further company coverage: IMNM.O
Recent news on Immunome
See all newsBrief: Immunome - Enters Amendment No. 4 To License Agreement With Bristol-Myers Squibb Company On Oct 2, 2026
US STOCKS ON THE MOVE-Cardinal Health, nVent, Acuity
U.S. STOCKS ON THE MOVE-Cardinal Health, Fervo Energy, Rocket Lab
U.S. STOCKS ON THE MOVE-Progress Software, Vicor Corp, Accenture
Immunome climbs as Stifel initiates coverage